Wall Street Analysts Weigh In on Top Stocks: Amazon, Alphabet, Cardlytics, MercadoLibre, and Nurix Therapeutics

Wall Street analysts have been busy initiating coverage on some of the most prominent companies, providing valuable insights and price targets for investors. Here’s a breakdown of the recent recommendations:

Amazon.com, Inc. (AMZN)

Jeffrey Wlodarczak, an analyst at Pivotal Research, initiated coverage on Amazon with a Buy rating and a price target of $260. This bullish outlook comes as Amazon shares closed at $186.65 on Thursday, gaining 0.8% for the day.

Alphabet Inc. (GOOG)

Scotiabank analyst Nat Schindler also initiated coverage on Alphabet, assigning a Sector Outperform rating and setting a price target of $212. Alphabet shares closed at $163.18 on Thursday, a slight increase of 0.1%.

Cardlytics, Inc. (CDLX)

Evercore ISI Group analyst Mark Mahaney initiated coverage on Cardlytics with an In-Line rating and a price target of $4. However, Cardlytics shares ended the day down 1.2% at $3.22.

MercadoLibre, Inc. (MELI)

Redburn Atlantic analyst Gonzalo Lopez initiated coverage on MercadoLibre with a Buy rating and an ambitious price target of $2,800. Despite this optimistic outlook, MercadoLibre shares closed at $2,040.50 on Thursday, down 0.4% for the day.

Nurix Therapeutics, Inc. (NRIX)

Jefferies analyst Roger Song initiated coverage on Nurix Therapeutics with a Buy rating and a price target of $41. Nurix Therapeutics shares closed at $21.86 on Thursday, slightly down by 0.6% for the day.

These analyst ratings and price targets provide valuable information for investors considering investing in these companies. However, it’s crucial to conduct your own thorough research and consider these recommendations alongside other factors before making any investment decisions.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top